Jump to content

Huma (company): Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Tags: Mobile edit Mobile web edit
Reverted to revision 825880973 by Behzad.samadi (talk): Unexplained rmal. (TW)
Line 19: Line 19:
Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including [[X-ray]]s and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, [[Apple Inc|Apple]] HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.<ref name=newscientist />
Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including [[X-ray]]s and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, [[Apple Inc|Apple]] HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.<ref name=newscientist />


Carl Reynolds, head of [[Open Health Care UK]] told ''New Scientist'' that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system.<ref name=newscientist/>
Carl Reynolds, head of [[Open Health Care UK]] told ''New Scientist'' that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system. Medopad will cost hospitals between £50 and £90 per month per user to license.<ref name=newscientist/>


=== Cancer ===
=== Cancer ===

Revision as of 21:09, 20 February 2018

Medopad Ltd
Company typePrivate
Industryhealthcare, big data, small data, mobile, internet of things, pharma, wearables
Founded2011
Headquarters
London, UK
Websitewww.medopad.com

Medopad Ltd is a private healthcare AI company specialising in remote patient monitoring.  Headquartered in the UK, it is primarily focused on connecting doctors and patients via mobile devices, using analytical data collection to create personalised care solutions. It produces applications that integrate health data from existing hospital databases as well as patient wearables and other mobile devices and securely transmits it for use by doctors.[1][2] It is partnered with some of the world’s leading technology companies including HP and Tencent.  Its offices are in London and Shanghai. In 2016 KPMG’s David Allessie named Medopad a $1B Healthtech company in the making[3].

In January 2018 Medopad was invited to join UK Prime Minister Theresa May on her trade mission[4] to China meeting President Xi.  During the trip it announced over £100m of commercial contracts[5] with major Chinese and international organisations including China Resources and Peking University.

Products

Enterprise

Medopad allows hospitals to pool their patient data into a single platform so it can be served to doctors' mobile devices in real-time.[6][7] Healthcare professionals can securely access lab results, images, clinical notes, and primary care data via iPads and other mobile devices.[8] In November 2013, Medopad became the first enterprise-class mobile health information system to receive CE approval.[9]

Some of the clinical applications that Medopad include editing patient records by voice recognition or typing, scheduling, lab results, image viewing including X-rays and CT scans, electronic support documents, taking and sending photos, video conferencing, primary records, transmitting real-time vital signs, collecting and managing demographic and contact details, Apple HealthKit integration, and arbitrage system to sort and prioritise patients, hospital admission, and access to more third party applications integrated into Medopad through the Clinical App Store.[1]

Carl Reynolds, head of Open Health Care UK told New Scientist that an open system that worked on multiple devices would be preferential to Medopad as it would avoid locking hospitals into a single system. Medopad will cost hospitals between £50 and £90 per month per user to license.[1]

Cancer

In April 2015, Medopad launched a chemotherapy application for monitoring cancer patients designed specifically for the Apple Watch.[10][11][12][13]

Investors

Some of Medopad's institutional investors are Healthbox and Sandbox Industries.[14][15] Lord Howard Flight and Tony Brown, Non-Executive Director of the NHS both invested individually.[16]

References

  1. ^ a b c "NewScientist". Retrieved 16 June 2014.
  2. ^ "Journal of mHealth - Real-time clinical information platform driving improved outcomes". Retrieved 30 October 2015.
  3. ^ "KPMG: Medopad, a $1B HealthTech company in the making". 2016-02-24. Retrieved 2018-02-15.
  4. ^ "May hails 'first step' to China trade deal". BBC News. 2018-02-01. Retrieved 2018-02-15.
  5. ^ Field, Matthew (2018-02-02). "UK healthtech startup Medopad plans $120m fund raise in China deal". The Telegraph. ISSN 0307-1235. Retrieved 2018-02-15.
  6. ^ "Financial Times". Retrieved 30 October 2014.
  7. ^ "BBC World News Business Edition: Medopad platform technology transforms patient care while improving efficiency and saving cost". Retrieved 30 October 2015.
  8. ^ "University of Oxford's Tata Idea Idol Competition". Retrieved 17 June 2014.
  9. ^ "Mobile health provider becomes first to receive CE approval". Retrieved 16 June 2014.
  10. ^ "The Journal of mHealth". The Journal of mHealth. Retrieved June 4, 2016.
  11. ^ "The Lancet Oncology". Retrieved 29 October 2015.
  12. ^ "The Stack". Retrieved 29 October 2015.
  13. ^ "Bedside manners: Small data from patients at home will mean big cost savings". The Economist. 30 May 2015. Retrieved 29 October 2015.
  14. ^ "'Dragons' Den' event promotes innovation in healthcare". Retrieved 17 June 2013.
  15. ^ "Company Overview". Retrieved 19 June 2014.
  16. ^ "NHS Board of Directors" (PDF). Retrieved 17 June 2014.

Further reading

Retrieved from "https://en.wikipedia.org/w/index.php?title=Huma_(company)&oldid=826757000"